Intervention Protocol

Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease

  1. Jan C Preiss1,*,
  2. Antje Timmer2

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD007572


How to Cite

Preiss JC, Timmer A. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007572. DOI: 10.1002/14651858.CD007572.

Author Information

  1. 1

    Charité - Universitätsmedizin Berlin, Med. Klinik I, Berlin, Germany

  2. 2

    German Cochrane Center, Department of Medical Biometry and Statistics, Freiburg, Germany

*Jan C Preiss, Med. Klinik I, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, 12203, Germany. jan.preiss@charite.de.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy and safety of IL-12/23p40-antibodies for induction of remission in Crohn's disease.